Clinical characteristics and treatment outcomes in 132 patients with malignant mesothelioma

Lung India

Volumn 28, Issue 4, 2011, Pages 267-271

  Abakay, Abdurrahman ^a   Tanrikulu, Abdullah C ^a   Kaplan, Muhammet Ali ^a   Kucukoner, Mehmet ^a   Abakay, Ozlem ^a   Sen, Hadice ^a   Isikdogan, Abdurrahman ^a   Senyigit, Abdurrahman ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

Asbestos; chemotherapy; lung cancer; mesothelioma

Indexed keywords

ASBESTOS; CARBOPLATIN; CISPLATIN; DOCETAXEL; GEMCITABINE; LACTATE DEHYDROGENASE; PEMETREXED;

ADULT; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; DYSPNEA; ENVIRONMENTAL EXPOSURE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE COUNT; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT MESOTHELIOMA; MULTIMODALITY CANCER THERAPY; PLEURODESIS; RETROSPECTIVE STUDY; SURVIVAL TIME; THORAX PAIN; THROMBOCYTE COUNT; THROMBOCYTOSIS; TREATMENT OUTCOME; TREATMENT RESPONSE; WEIGHT REDUCTION;

EID: 80055024607     PISSN: 09702113     EISSN: 0974598X     Source Type: Journal    
DOI: 10.4103/0970-2113.85688     Document Type: Article

References (26)

1. O'Reilly KM, McLaughin AM, Beckett WS, Sime PJ. Asbestos related lung disease. Am Fam Physician 2007;75:683-8.
2. Gibbs AR. Role of asbestos and other fibres in the development of diffuse malignant mesothelioma. Thorax 1990;45:649-54. (Pubitemid 20328037)
3. Aisner J. Current approach to malignant mesothelioma of the pleura. Chest 1995;107:332-44.
4. Metintas M, Ozdemir N, Hillerdal G, Uçgun I, Metintas S, Baykul C, et al. Environmental asbestos exposure and malignant pleural mesothelioma. Respir Med 1999;93:349-55. (Pubitemid 29209882)
5. Selçuk ZT, Cöplü L, Emri S, Kalyoncu AF, Sahin AA, Bari YI. Malignant pleural mesothelioma due to environmental mineral fiber exposure in Turkey. Analysis of 135 cases. Chest 1992;102:790-76.
6. Tanrikulu AC, Senyigit A, Dagli CE, Babayigit C, Abakay A. Environmental malignant pleural mesothelioma in SoutheastTurkey. Saudi Med J 2006;27:1605-7. (Pubitemid 351833183)
7. Cil T, Isikdogan A, Onat S, Zincircioglu B, Ulku R, Özekinci S, et al. Single center experience of mesothelioma patients in southeast region of Turkey. UHOD 2009;19:153-8.
8. Senyiit A, Babayiit C, Gökirmak M, Topçu F, Asan E, Cokunsel M, et al. Incidence of malignant pleural mesothelioma due to environmental asbestos fiber exposure in the southeast of Turkey. Respiration 2000;67:610-4. (Pubitemid 32010731)
9. Montanaro F, Rosato R, Gangemi M, Rosato R, Ricceri F, Merler E, et al. Survival of pleural malignant mesothelioma in Italy: A population-based study. Int J Cancer 2009;124:201-7.
10. Borasio P, Berruti A, Billé A, Lausi P, Levra MG, Giardino R, et al. Malignant pleural mesothelioma: Clinicopathologic and survival characteristics in a consecutive series of 394 patients. Eur J Cardiothorac Surg 2008;33:307-13.
11. Batirel HF, Metintas M, Caglar HB, Yildizeli B, Lacin T, Bostanci K, et al. Trimodality treatment of malignant pleural mesothelioma. J Thorac Oncol 2008;3:499-504. (Pubitemid 351630277)
12. Butchart EG, Ashcroft T, Barnsley WC, Holden MP. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. Thorax 1976;31:15-24.
13. Sugarbaker DJ, Norberto JJ. Multimodality management of malignant pleural mesothelioma. Chest 1998;113:61S-5. (Pubitemid 28051737)
14. Ceresoli GL, Chiti A, Zucali PA, Cappuzzo F, De Vincenzo F, Cavina R, et al. Assessment of tumor response in malignant pleural mesothelioma. Cancer Treat Rev 2007;33:533-41. (Pubitemid 47355343)
15. Yazicioglu S, Ilçayto R, Balci K, Sayli BS, Yorulmaz B. Pleural calcification, pleural mesotheliomas and bronchial cancers caused by tremolite dust. Thorax 1980;35:564-9. (Pubitemid 10055760)
16. Hillerdal G. Mesothelioma: Cases associated with non-occupational and low dose exposures. Occup Environ Med 1999;56:505-13. (Pubitemid 29352035)
17. Senyiit A, Bayram H, Babayiit C, Topçu F, Nazarolu H, Bilici A, et al. Malignant pleural mesothelioma caused by environmental exposure to asbestos in the Southeast of Turkey: CT findings in 117 patients. Respiration 2000;67:615-22. (Pubitemid 32008887)
18. van Gelder T, Hoogsteden HC, Vandenbroucke JP, van der Kwast TH, Planteydt HT. The influence of the diagnostic technique on the histopathological diagnosis in malignant mesothelioma. Virchows Archiv A Pathol Anat Histopathol 1991;418:315-7.
19. Craighead JE, Kane AB. The pathogensis of malignant and nonmalignant serosal lesions in body cavities consequent to asbestos exposure. In: Jauren MC, Bignon J. editors. Mesothelial cell and mesothelioma, 1st ed. New York: Marcel Dekker; 1994.p.79-101.
20. Chapman A, Mulrennan S, Ladd B, Muers MF. Population based epidemiology and prognosis of mesothelioma in Leeds, UK. Thorax 2008;63:435-9. (Pubitemid 351692353)
21. Muers MF, Stephens RJ, Fisher P, Darlison L, Higgs CM, Lowry E, et al. Active symptom control with or without chemotherapy in the malignant pleural mesothelioma (MS01): A multicentre randomized trial. Lancet 2008;371:1685-94. (Pubitemid 351671885)
22. Ak G, Metintas S, Metintas M, Yildirim H, Erginel S, Kurt E, et al. Prognostic factors according to the treatment schedule in malignant pleural mesothelioma. J Thorac Oncol 2009;4:1425-30.
23. van Meerbeeck JP, Gaafar R, Manegold C, Van Klaveren RJ, Van Marck EA, Vincent M, et al. Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: An intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada. J Clin Oncol 2005;23:6881-9.
24. Schipper PH, Nichols FC, Thomse KM, Deschamps C, Cassivi SD, Allen MS, et al. Malignant pleural mesothelioma: Surgical management in 285 patients. Ann Thorac Surg 2008;85:257-64. (Pubitemid 350265795)
25. Byrne MJ, Davidson JA, Musk AW, Dewar J, van Hazel G, Buck M, et al. Cisplatin and gemcitabine treatment for malignant mesothelioma: A phase II study. J Clin Oncol 1999;17:25-30. (Pubitemid 29022374)
26. Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003;21:2636-44. (Pubitemid 46606305)